Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 2 · 100%High 0 · 0%

Mucosal healing · Patients with active Crohn's disease

Azathioprine + infliximab probably leads to higher mucosal healing compared with infliximab (moderate certainty).

1 finding from 1 review

Azathioprine or 6‐mercaptopurine for induction of remission in Crohn's disease 2016 · Cochrane Headline outcomes only
RR 1.5 [1.02, 2.19]
1 study · 210 participants
Moderate

Mucosal healing · Patients with active Crohn's disease

Azathioprine probably leads to lower mucosal healing compared with infliximab (moderate certainty).

1 finding from 1 review

Azathioprine or 6‐mercaptopurine for induction of remission in Crohn's disease 2016 · Cochrane Headline outcomes only
RR 0.55 [0.33, 0.94]
1 study · 214 participants
Moderate